HTR2A and major depressive disorder: The addition of aripiprazole, due to its partially agonistic dopaminergic effect and its 5HT2 receptor antagonism, has proven to be effective in improving sexual desire and sexual satisfaction in monotherapy refractory depression, although only in women [96].